Capsule Endoscopy — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Capsule endoscopy is a painless, non-invasive diagnostic technique in which the patient swallows a vitamin-sized wireless camera capsule (11 mm × 26 mm) that photographs the entire digestive tract as it travels naturally by peristalsis. The capsule contains a miniature colour camera, LED light sources, a battery lasting 8–12 hours, a radio transmitter, and an antenna. It captures 2–6 images per second — amounting to 50,000–100,000 images over the recording period — which are transmitted wirelessly to sensors worn on the patient's abdomen connected to a portable data recorder. After the recording session, images are downloaded and reviewed using dedicated software by a gastroenterologist. Capsule endoscopy is the only technique that provides complete visualisation of the small bowel, an area of 6–7 metres inaccessible to standard upper and lower endoscopy. It does not provide biopsy capability or therapeutic intervention — these require double-balloon enteroscopy if a lesion is identified. The colon capsule endoscopy (PillCam COLON) is a separate formulation for colorectal assessment. Capsule endoscopy is a painless, non-invasive diagnostic technique in which the patient swallows a vitamin-sized wireless camera capsule that photographs the entire digestive tract as it travels naturally by peristalsis. The capsule contains a miniature colour camera, LED light sources, a battery, and a radio transmitter. It captures 2–8 images per second throughout its 6–8 hour battery life, transmitting images wirelessly to a recording device worn by the patient as a belt or vest. Capsule endoscopy was first approved for clinical use in 2000 and has become the gold-standard investigation for small bowel pathology — a region inaccessible to conventional upper and lower gastrointestinal endoscopy. The images are downloaded and reviewed by a gastroenterologist using dedicated software that enables review of over 50,000 images in 30–60 minutes. Over 2 million capsule endoscopy procedures are performed globally each year.

Capsule endoscopy is indicated when standard upper endoscopy (gastroscopy) and colonoscopy have failed to identify the cause of symptoms. The primary indication is obscure gastrointestinal bleeding — either overt (visible haematochezia or melaena with negative conventional endoscopy) or occult (iron-deficiency anaemia of unknown cause). It is superior to barium follow-through and CT enterography for detecting small bowel angioectasias, Dieulafoy lesions, and polyps in the setting of bleeding. Suspected or established Crohn's disease of the small bowel is a major indication when the diagnosis is unclear or to assess disease extent and activity beyond the terminal ileum. Small bowel tumour surveillance in polyposis syndromes, including Peutz-Jeghers syndrome (where hamartomatous polyps require monitoring) and Lynch syndrome, is an established indication. Other uses include evaluation of coeliac disease extent and mucosal healing assessment, and surveillance of familial adenomatous polyposis. Contraindications include known or suspected intestinal stricture, swallowing disorders, and pregnancy.

Bowel preparation consists of clear fluids for 12–24 hours before the procedure and a PEG-based laxative on the evening before to improve small bowel cleansing and capsule transit. On the morning of the procedure, the patient attaches the sensor array belt to the abdomen, which connects to the data recorder worn over the shoulder. The capsule is swallowed with water under supervision. The patient is instructed not to eat for 2 hours and to avoid strenuous activity and areas of strong electromagnetic fields during recording. After 2 hours, clear fluids are permitted; a light meal is allowed at 4 hours. The capsule transmits images continuously until battery depletion. After 8–12 hours, the recording device is returned to the endoscopy unit. The sensor vest is removed and the data downloaded. A gastroenterologist reviews the approximately 50,000 images using software that includes automated blood detection algorithms to flag suspicious areas. The report is typically issued within 3–7 working days. The capsule is excreted naturally — usually within 24–72 hours — and does not need to be retrieved. Confirmation of excretion is recommended in patients at risk of retention. Bowel preparation consists of clear fluids for 12–24 hours before the procedure and an optional PEG-based laxative on the evening before to improve small bowel cleansing and capsule transit. On the morning of the procedure, the patient attaches the sensor array belt and swallows the capsule with a glass of water. The patient may resume light activities and eat a light snack after two hours. The capsule passes through the oesophagus in seconds, images the stomach and duodenum within 20–30 minutes, and traverses the entire small bowel over the following 4–6 hours. Natural excretion in the stool occurs within 24–72 hours — the capsule is disposable and does not need to be recovered. The recording device is returned to the endoscopy unit at the end of the study day. Software with AI-assisted flagging identifies abnormal findings — blood, mucosal breaks, polyps, and angioectasias — for review by the gastroenterologist.

Capsule endoscopy detects small bowel pathology in 50–70% of patients with obscure gastrointestinal bleeding — significantly superior to small bowel follow-through radiology (20–30%) and CT enterography (40–50%) for vascular lesions and flat mucosal abnormalities. In iron-deficiency anaemia, the diagnostic yield is highest when performed closest to the bleeding episode. Angioectasias (arteriovenous malformations) are the most common finding (40–50%), followed by small bowel tumours (5–10%) and Crohn's lesions. For suspected Crohn's disease, capsule endoscopy identifies small bowel lesions in 60–70% of cases, superior to MR enterography for detection of early mucosal changes not visible on cross-sectional imaging. In Peutz-Jeghers syndrome surveillance, capsule endoscopy detects polyps requiring enteroscopic removal with high sensitivity. Colon capsule endoscopy achieves sensitivity of 86–88% and specificity of 88–95% for polyps greater than 6 mm compared with colonoscopy, with patient acceptability superior to standard colonoscopy.

Capsule endoscopy is one of the safest diagnostic procedures in gastroenterology. The primary risk is capsule retention within a bowel stricture, occurring in 1–2% of all studies and in up to 13% of patients with known Crohn's disease. Retained capsules require endoscopic or surgical retrieval. To mitigate this risk, a dissolving patency capsule (Agile) of identical dimensions can be administered first — if it passes within 30–40 hours (confirmed by abdominal X-ray or fluoroscopic detection), the diagnostic capsule can be safely used. CT enterography before capsule endoscopy also helps identify suspected strictures. Failure to complete small bowel transit during the 8–12 hour recording period (incomplete examination) occurs in 15–20% of studies due to slow gastric emptying or slow small bowel transit; a prokinetic agent (metoclopramide) given at ingestion reduces this rate. Aspiration during swallowing is rare and occurs predominantly in elderly patients with dysphagia — delivery by overtube or endoscopic capsule delivery system is available. No radiation is involved.

No recovery period is required after capsule endoscopy. Patients proceed with normal daily activities throughout the recording day, with the only restrictions being avoiding strenuous exercise and MRI scanning while the capsule is in transit. The sensor belt and recorder are returned to the unit after the recording period ends. Patients are advised to observe their stools for the capsule and confirm excretion within 2 weeks. If the capsule is not confirmed to have passed within 2 weeks, an abdominal X-ray determines whether it is still present. Most capsules pass within 24–72 hours. There are no dietary restrictions after completing the recording session. Results are available within 3–7 working days, and the referring physician communicates findings and any recommended further investigation (double-balloon enteroscopy for therapeutic intervention if a lesion is identified). No medication changes are typically required post-procedure.